Peking University Medicine Co., Ltd.

Announcement on the Expiration of the Share Reduction Plan for Shareholders Holding More than 5% of Shares and Implementation Status

Announcement on the Progress of Judicial Enforcement on Shares Held by Shareholders Holding More than 5% and Touching 1% Integer Multiple

Announcement on Obtaining the Approval Notice for the Listing Application of Chemical Raw Material Drugs

Pre-disclosure Announcement Regarding Judicial Disposal of Shares by Shareholders Holding More Than 5%

Announcement on the proposed reappointment of the accounting firm

Financial settlement report for the year 2025

Board of directors' work report for the year 2025

Special explanation on the securities investment situation of the company's wholly-owned subsidiary for the year 2025

Announcement on the confirmation of the remuneration of directors and senior management for the year 2025

Independent director's work report for the year 2025 (Wang Weining)

Independent director's work report for the year 2025 (Zeng Jianguang)

Independent director's work report for the year 2025 (Jin Jingyu)

Internal control audit report for the year 2025

Internal control evaluation report for the year 2025

Cash management system of Peking University Medicine Co., Ltd.

Announcement on the provision for asset impairment for the year 2025

Announcement on the estimated amount of daily related transactions for the year 2026 and the supplementary confirmation of daily related transactions for the year 2025

Notice of the Annual Shareholders' Meeting for 2025

Announcement of the Resolutions of the Nineteenth Meeting of the Eleventh Board of Directors

Announcement on the Proposed Non-Distribution of Profits for 2025

2026 First Quarter Report

Evaluation Report on the Performance of the Accounting Firm for 2025 and the Report of the Board of Directors' Audit Committee on the Supervision Responsibilities of the Accounting Firm

Special Audit Explanation by the Accounting Firm on Non-Operating Fund Occupation and Other Related Party Fund Transactions

Summary Table of Non-Operating Fund Occupation and Other Related Fund Transactions of Listed Companies

Board of Directors' Special Opinion on the Self-Examination of Independent Directors' Independence

2025 Annual Audit Report

2025 Annual Report

2025 Annual Report Summary

Announcement on the Use of Idle Self-owned Funds for Cash Management

Announcement on Shareholders Holding More Than 5% Reducing Their Shareholding Proportion Touching 1% and 5% Integer Multiples

Simplified Equity Change Report of Peking University Medicine Co., Ltd.

Announcement on Abnormal Fluctuations in Stock Trading

Announcement on Obtaining the 'Approval Notice for Marketing Application of Chemical Raw Materials'

Announcement on the Resignation of Senior Management Personnel of the Company

Announcement on the Implementation of Equity Distribution for the First Three Quarters of 2025